IRIS
FORMICA, VINCENZO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 20.233
AS - Asia 3.189
EU - Europa 2.270
SA - Sud America 531
AF - Africa 38
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 6
Totale 26.276
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 20.143
SG - Singapore 1.512
CN - Cina 587
BR - Brasile 455
IT - Italia 446
RU - Federazione Russa 425
HK - Hong Kong 366
VN - Vietnam 278
DE - Germania 261
UA - Ucraina 237
IE - Irlanda 218
FR - Francia 154
JP - Giappone 122
GB - Regno Unito 115
FI - Finlandia 107
SE - Svezia 84
PL - Polonia 83
KR - Corea 62
IN - India 56
CA - Canada 43
NL - Olanda 38
BD - Bangladesh 37
ID - Indonesia 36
AR - Argentina 35
MX - Messico 30
IQ - Iraq 22
AT - Austria 21
ES - Italia 20
BE - Belgio 17
TR - Turchia 14
PK - Pakistan 13
EC - Ecuador 12
ZA - Sudafrica 12
SA - Arabia Saudita 10
AE - Emirati Arabi Uniti 8
EU - Europa 8
PH - Filippine 8
LT - Lituania 7
TH - Thailandia 7
CL - Cile 6
CO - Colombia 6
CZ - Repubblica Ceca 6
PY - Paraguay 6
AL - Albania 5
AU - Australia 5
CH - Svizzera 5
CR - Costa Rica 5
IL - Israele 5
MA - Marocco 5
MY - Malesia 5
TN - Tunisia 5
BG - Bulgaria 4
EG - Egitto 4
JM - Giamaica 4
KE - Kenya 4
KG - Kirghizistan 4
NP - Nepal 4
UZ - Uzbekistan 4
HN - Honduras 3
JO - Giordania 3
LB - Libano 3
PE - Perù 3
QA - Qatar 3
UY - Uruguay 3
VE - Venezuela 3
AZ - Azerbaigian 2
BY - Bielorussia 2
ET - Etiopia 2
GE - Georgia 2
GR - Grecia 2
IR - Iran 2
KW - Kuwait 2
MN - Mongolia 2
NI - Nicaragua 2
NO - Norvegia 2
OM - Oman 2
PA - Panama 2
PT - Portogallo 2
RO - Romania 2
RS - Serbia 2
SI - Slovenia 2
TW - Taiwan 2
AM - Armenia 1
AO - Angola 1
BH - Bahrain 1
CI - Costa d'Avorio 1
DZ - Algeria 1
GA - Gabon 1
GF - Guiana Francese 1
GY - Guiana 1
KH - Cambogia 1
KZ - Kazakistan 1
LU - Lussemburgo 1
LV - Lettonia 1
MT - Malta 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
SC - Seychelles 1
SN - Senegal 1
SV - El Salvador 1
Totale 26.274
Salva come PNG Salva come JPEG
Città #
Woodbridge 5.249
Wilmington 4.707
Houston 4.626
Singapore 813
Fairfield 573
Ashburn 440
San Jose 385
Hong Kong 361
Chandler 342
Ann Arbor 336
Seattle 261
Beijing 260
Cambridge 215
Jacksonville 213
Dublin 204
Medford 162
Rome 149
Dallas 143
Council Bluffs 138
New York 138
Santa Clara 127
The Dalles 119
Tokyo 109
Los Angeles 101
Dearborn 89
Ho Chi Minh City 89
Engelhard 85
Lawrence 72
Hanoi 68
Menlo Park 67
Kraków 64
Moscow 64
Buffalo 60
Lauterbourg 56
San Diego 46
Milan 43
Helsinki 41
Saint Petersburg 35
Orem 34
Chicago 33
Redondo Beach 33
São Paulo 33
Zhengzhou 33
Frankfurt am Main 25
Jakarta 25
Falls Church 24
Boardman 21
Chennai 19
Mülheim 19
Nuremberg 19
London 18
Brussels 17
Montreal 16
North Bergen 16
Warsaw 16
Brooklyn 15
Lappeenranta 15
Mexico City 15
Rio de Janeiro 14
Belo Horizonte 13
Porto Alegre 13
Atlanta 12
Cagliari 12
San Francisco 12
Boston 11
Munich 11
Salt Lake City 11
Turin 11
Detroit 10
Nanjing 10
Norwalk 10
Phoenix 10
Seoul 10
Stockholm 10
Amsterdam 9
Haiphong 9
Hangzhou 9
Hefei 9
Mumbai 9
Redwood City 9
Shanghai 9
Vienna 9
Bologna 8
Brasília 8
Curitiba 8
Denver 8
Kunming 8
Manchester 8
Palo Alto 8
Vancouver 8
Charlotte 7
Johannesburg 7
Mannheim 7
Salvador 7
Sorocaba 7
Baghdad 6
Bangkok 6
Campinas 6
Columbus 6
Creede 6
Totale 21.877
Salva come PNG Salva come JPEG
Nome #
A novel method for monitoring response to chemotherapy based on the detection of circulating cancer cells: a case report 530
Preclinical studies on detection of circulating melanoma cells in patients: Telomerase as a recognition marker of malignancy 495
Drug-induced increase of carcinoembryonic antigen expression in cancer cells 488
Role of CA19.9 in predicting bevacizumab efficacy for metastatic colorectal cancer patients 472
Impact of endoscopic ultrasound-guided fine-needle aspiration and multidisciplinary approach in the management of abdominal or mediastinal mass 466
Predictive value of high-sensitive D-dimer determination for chemotherapy-associated venous thromboembolism in gastrointestinal cancer patients 462
Effects of conventional therapeutic interventions on the number and function of regulatory T cells 460
Biological and predictive role of ERCC1 polymorphisms in cancer 460
Detection of circulating tumor cells is improved by drug-induced antigen up-regulation: preclinical and clinical studies 457
Immune reaction and colorectal cancer: friends or foes? 451
TNF-α gene promoter polymorphisms and risk of venous thromboembolism in gastrointestinal cancer patients undergoing chemotherapy 451
Prognostic value of glycated hemoglobin in colorectal cancer 451
Treatment of peripheral blood with staurosporine increases detection of circulating carcinoembryonic antigen positive tumor cells 449
Venous thromboembolism risk prediction in ambulatory cancer patients: Clinical significance of neutrophil/lymphocyte ratio and platelet/lymphocyte ratio 449
Prognostic value of carcinoembryonic antigen and vascular endothelial growth factor tumor tissue content in colorectal cancer 440
Thromboembolic events in patients treated with anti-angiogenic drugs 437
Are there alternative ways to quantify the real benefit of novel agents in oncology? - The 'death pace' 434
Rehabilitation in neuro-oncology: a meta-analysis of published data and a mono-institutional experience 428
Association between increased tumor necrosis factor alpha levels and acquired activated protein C resistance in patients with metastatic colorectal cancer 427
Pretreatment Insulin Levels as a Prognostic Factor for Breast Cancer Progression 426
Family history of cancer in patients with gastric cancer 424
The Medical Care Continuity (MCC) project. A pilot study of video-assisted home care within the eTEN European Community program. The Italian experience 416
VEGF gene promoter polymorphisms and risk of VTE in chemotherapytreated cancer patients 416
Insulinemia and the risk of breast cancer and its relapse 415
CD26: a multi-purpose pharmacological target 410
Ensuring Sample Quality for Biomarker Discovery Studies - Use of ICT Tools to Trace Biosample Life-cycle 408
The association of clinical outcome and peripheral T-cell subsets in metastatic colorectal cancer patients receiving first-line FOLFIRI plus bevacizumab therapy 405
Up-regulation of carcinoembryonic antigen (CEA) expression by staurosporine in circulating colon cancer cells 402
Neutrophil/lymphocyte ratio helps select metastatic pancreatic cancer patients benefitting from oxaliplatin 402
VEGF gene polymorphisms may be associated with an increased risk of fluorouracil-induced diarrhea 401
Kallikrein-related peptidases targeted therapies in prostate cancer: Perspectives and challenges 392
Targeted therapy in first line treatment of RAS wild type colorectal cancer 392
A comprehensive procedural approach to genotyping KRAS and BRAF from paraffin embedded tissues for diagnostic purposes 390
Dendritic cell-mediated cross-presentation of antigens derived from colon carcinoma cells exposed to a highly cytotoxic multidrug regimen with gemcitabine, oxaliplatin, 5-fluorouracil, and leucovorin, elicits a powerful human antigen-specific CTL response with antitumor activity in vitro 388
Systemic inflammation, as measured by the neutrophil/lymphocyte ratio, may have differential prognostic impact before and during treatment with fluorouracil, irinotecan and bevacizumab in metastatic colorectal cancer patients 385
Caregiver distress in the early phases of cancer 384
Prognostic significance of serum adipokine levels in colorectal cancer patients 377
Peripheral CD45RO, PD-1, and TLR4 expression in metastatic colorectal cancer patients treated with bevacizumab, fluorouracil, and irinotecan (FOLFIRI-B) 377
Targeting metastatic castration-resistant prostate cancer: mechanisms of progression and novel early therapeutic approaches 375
Treatment of peripheral blood with staurosporine increases detection of circulating carcinoembryonic antigen positive tumor cells 373
Predictive value of VEGF gene polymorphisms for metastatic colorectal cancer patients receiving first-line treatment including fluorouracil, irinotecan, and bevacizumab 367
Non-steroidal anti-inflammatory drugs in cancer prevention and therapy 362
Percutaneous combined therapy for painful sternal metastases: a radiofrequency thermal ablation (RFTA) and cementoplasty protocol 346
A novel K-ras mutation in colorectal cancer. A case report and literature review 344
Plasma plasminogen activator inhibitor-1 (PAI-1) levels in breast cancer - relationship with clinical outcome 344
Predictive factors for 6 vs 12 cycles of Folfiri-Bevacizumab in metastatic colorectal cancer 343
Review. TNF/VEGF cross-talk in chronic inflammation-related cancer initiation and progression: an early target in anticancer therapeutic strategy 330
Clinical significance of glycemic parameters on venous thromboembolism risk preDiction in gastrointestinal cancer 323
Chemotherapy in patients with hereditary angioedema 322
Case report of a patient with breast metastasis from gastric cancer treated with paclitaxel and ramucirumab plus regional hyperthermia 312
Cancer patients in the emergency department: A "nightmare" that might become a virtuous clinical pathway 299
Histotype influences emergency presentation and prognosis in colon cancer surgery 242
Relevance of computed tomography and magnetic resonance imaging for penile metastasis after prostatectomy: uncommon case report and brief review of the literature 226
Complete blood count might help to identify subjects with high probability of testing positive to SARS-CoV-2 209
A nomogram to predict neutropenia in metastatic pancreatic cancer patients treated with gemcitabine/nab-paclitaxel 180
Gastric Inflammatory Prognostic Index (GIPI) in Patients with Metastatic Gastro-Esophageal Junction/Gastric Cancer Treated with PD-1/PD-L1 Immune Checkpoint Inhibitors 174
Factors influencing diagnostic accuracy of endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) in pancreatic and biliary tumors 148
Hemoglobin level and XRCC1 polymorphisms to select patients with locally advanced rectal cancer candidate for neoadjuvant chemoradiotherapy with concurrent capecitabine and a platinum salt 141
Clinical care pathway program versus open-access system: a study on appropriateness, quality, and efficiency in the delivery of colonoscopy in the colorectal cancer 135
Clinical utility of plasma KRAS, NRAS and BRAF mutational analysis with real time PCR in metastatic colorectal cancer patients -The importance of tissue/plasma discordant cases 126
Effectiveness of Immunotherapy in Non-Small Cell Lung Cancer Patients with a Diagnosis of COPD: Is This a Hidden Prognosticator for Survival and a Risk Factor for Immune-Related Adverse Events? 121
Irinotecan or oxaliplatin: which is the first move for the mate? 118
Prognostic impact and clinical management of pT4N0 colon cancer: data from a large, multicenter, international, real-world dataset 114
Mucinous and Signet-Ring Cell Colonic Adenocarcinoma in Inflammatory Bowel Disease: A Case-Control Study 112
Venous Thromboembolism in Cancer Patients on Simultaneous and Palliative Care 111
Lymph node-only metastatic gastric/gastroesophageal junction cancer and efficacy of immunotherapy 110
Obesity and Breast Cancer: Interaction or Interference with the Response to Therapy? 107
KRAS and BRAF Mutations in Stage II/III Colon Cancer: A Systematic Review and Meta-Analysis 106
Durvalumab Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Biliary Tract Cancer: a Real-World Retrospective, Multicenter Study 104
A validated prognostic classifier for V600EBRAF-mutated metastatic colorectal cancer: the ?BRAF BeCool? study 99
Noninferiority of three months versus six months of oxaliplatin-based adjuvant chemotherapy for resected colon cancer. How should IDEA findings affect clinical practice? 99
The effects of association of topical polydatin improves the preemptive systemic treatment on EGFR inhibitors cutaneous adverse reactions 98
A systematic review and meta-analysis of PD-1/PD-L1 inhibitors in specific patient subgroups with advanced gastro-oesophageal junction and gastric adenocarcinoma 93
Endoscopic Ultrasound Plus Endoscopic Retrograde Cholangiopancreatography Based Tissue Sampling for Diagnosis of Proximal and Distal Biliary Stenosis Due to Cholangiocarcinoma: Results from a Retrospective Single-Center Study 93
Irinotecan- vs. Oxaliplatin-Based Doublets in KRASG12C-Mutated Metastatic Colorectal Cancer-A Multicentre Propensity-Score-Matched Retrospective Analysis 92
HIF2α, Hepcidin and their crosstalk as tumour-promoting signalling 91
Total neoadjuvant therapy for the treatment of locally advanced rectal cancer: a systematic minireview 87
Untailored vs. Gender- and Body-Mass-Index-Tailored Skeletal Muscle Mass Index (SMI) to Assess Sarcopenia in Advanced Head and Neck Squamous Cell Carcinoma (HNSCC) 86
MiRNAs and circRNAs for the Diagnosis of Anthracycline-Induced Cardiotoxicity in Breast Cancer Patients: A Narrative Review 85
Role of systemic inflammation and CD45RO+CD8+ cells in metastatic colorectal cancer = Ruolo dell’infiammazione e delle cellule CD45RO+CD8+ nei tumori colorettali metastatici 84
Health-related quality of life in patients with advanced colorectal cancer: a predictive nomogram including BMI, sex and age 82
Life-threatening toxic epidermal necrolysis during voriconazole therapy for invasive aspergillosis after chemotherapy [3] 81
Solitary metachronous gastric metastasis from pulmonary adenocarcinoma: Report of a case 81
Concordance of blood-based and normal tissue-based dihydropyrimidine dehydrogenase (DPYD) genotyping 80
Immune Response in Vitamin D Deficient Metastatic Colorectal Cancer Patients: A Player That Should Be Considered for Targeted Vitamin D Supplementation 79
Gender differences in cancer-associated venous thromboembolism 77
Targeting hepcidin in colorectal cancer triggers a TNF-dependent-gasdermin E-driven immunogenic cell death response 76
Nutritional index for immune-checkpoint inhibitor in patients with metastatic gastro-esophageal junction/gastric cancer 76
Role of systemic inflammation and CD45RO+CD8+ cells in metastatic colorectal cancer = Ruolo dell’infiammazione e delle cellule CD45RO+CD8+ nei tumori colorettali metastatici 76
Randomized phase II trial of avelumab alone or in combination with cetuximab for patients with previously treated, locally advanced, or metastatic squamous cell anal carcinoma: The CARACAS study 73
Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer: An early exploratory analysis of real-world data 72
Hepcidin Upregulation in Colorectal Cancer Associates with Accumulation of Regulatory Macrophages and Epithelial–Mesenchymal Transition and Correlates with Progression of the Disease 68
Adjuvant therapy for very young women with breast cancer: Response according to biologic and endocrine features 68
Circulating Hepcidin Levels Are an Independent Predictor of Survival in Microsatellite Stable Metastatic Colorectal Cancer Patient Candidates for Standard First-Line Treatment 67
Estimating 12-week death probability in patients with refractory metastatic colorectal cancer: The Colon Life nomogram 67
Issues and promises of bevacizumab in prostate cancer treatment 63
Obesity and common pathways of cancer and cardiovascular disease 59
Impact of body composition on survival of PD-1/PD-L1-treated metastatic gastro-esophageal junction/gastric cancer 58
5-Fluorouracil can cross brain-blood barrier and cause encephalopathy: Should we expect the same from capecitabine? A case report on capecitabine-induced central neurotoxicity progressing to coma 57
Antioxidant activity of phenolic extracts from different cultivars of Italian onion (Allium cepa) and relative human immune cell proliferative induction 55
Totale 25.763
Salva come PNG Salva come JPEG
Categoria #
all - tutte 68.545
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 68.545
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021165 0 0 0 0 0 0 0 0 0 0 115 50
2021/2022855 32 81 38 48 44 70 75 65 67 86 49 200
2022/2023936 87 73 21 113 116 228 73 56 82 10 42 35
2023/2024567 40 16 36 20 33 103 176 51 7 4 5 76
2024/20252.499 56 488 207 125 33 182 165 160 443 254 203 183
2025/20264.326 367 278 630 387 406 192 496 583 530 403 54 0
Totale 26.697